{"id":61587,"date":"2025-07-16T04:03:41","date_gmt":"2025-07-16T02:03:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/"},"modified":"2025-07-16T04:03:41","modified_gmt":"2025-07-16T02:03:41","slug":"lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/","title":{"rendered":"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments"},"content":{"rendered":"
\n

\nInitiates Prearranged Financial Restructuring Process to Significantly Strengthen Balance Sheet<\/i><\/p>\n

\nOperations Continue in the Ordinary Course, Including Full Continuity of OneTouch<\/i>\u00ae Glucose Measurement and Management Offerings<\/i><\/p>\n

MALVERN, Pa.–(BUSINESS WIRE)–LifeScan, Inc. (\u201cLifeScan\u201d or the \u201cCompany\u201d), a world leader in blood glucose monitoring, today announced that it has entered into a Restructuring Support Agreement (\u201cRSA\u201d) with its first- and second-lien lenders and current equity sponsor, Platinum Equity, that will transform its balance sheet and position the Company for a stronger and more profitable future. As contemplated in the RSA, LifeScan expects to reduce more than 75% of its debt, which will enable the Company to accelerate strategic investments that will support the future of the business.<\/p>\n

<\/a>
<\/a><\/p>\n

\nTo implement the RSA as efficiently as possible, LifeScan filed voluntary petitions for prearranged chapter 11 cases in the United States Bankruptcy Court for the Southern District of Texas (the \u201cCourt\u201d). LifeScan\u2019s international subsidiaries are not included in the chapter 11 filing in the U.S. The Company expects to emerge from this process under the majority ownership of a group of the Company\u2019s existing lenders, with whom it has had a longstanding and productive relationship. Importantly, the Company\u2019s financial partners recognize the strong and growing potential of the glucose management industry, and through this process have committed their support for LifeScan\u2019s go-forward strategy.<\/p>\n

\n\u201cThis balance sheet restructuring will significantly strengthen LifeScan\u2019s financial position, enabling us to continue serving more than 20 million customers across 50+ countries and put new growth strategies in place,\u201d said Valerie Asbury, Chief Executive Officer of LifeScan. \u201cLifeScan is always evolving to meet the needs of our valued customers. In the U.S., we will continue to take action to expand access to OneTouch\u00ae so consumers can continue to manage their health with our reliable and affordable products, without the need for a prescription. We recognize that our products are essential for people with diabetes to make life-sustaining decisions and are evolving our model to bring products and services to market through multiple channels. I am deeply grateful for the partnership of our lenders and sponsor and the unyielding commitment of our employees, which will enable us to become a stronger company and create a world without limits for people with diabetes.\u201d<\/p>\n

\nWith a stronger financial foundation upon emerging from this process, LifeScan will be better positioned to invest in its global business. The Company will continue to prioritize product availability and superior customer service as it works proactively to become one of the most comprehensive players in the glucose management industry. As part of this effort, the Company intends to accelerate strategies in the U.S. market that offer both stronger economics and more predictable patient access.<\/p>\n

\nLifeScan will continue to operate in the ordinary course of business during its chapter 11 cases and is focused on delivering on its commitments to customers, vendors, and employees. The Company has filed a number of customary \u201cfirst day\u201d motions which, upon approval by the Court, will enable LifeScan to continue operating as usual, including continuing to pay employee wages and benefits, maintaining customer programs, and honoring post-petition obligations to vendors. The Company expects to have the necessary liquidity to support operations during this process and anticipates emerging from chapter 11 by the end of the year.<\/p>\n

\nAdditional information is available through the Company\u2019s claims agent, Epiq at https:\/\/dm.epiq11.com\/LifeScan<\/a>. Stakeholders with questions can contact Epiq by calling 888-832-9472 (U.S.\/Canada) or 971-318-6618 (International) or emailing lifescaninfo@epiqglobal.com<\/a>.<\/p>\n

\nAdvisors<\/b><\/p>\n

\nMilbank LLP and Porter Hedges LLP are serving as legal advisors, Alvarez & Marsal is serving as financial and restructuring advisor, PJT Partners LP is serving as investment banker, and C Street Advisory Group is serving as strategic communications advisor to the Company. Davis Polk & Wardwell LLP is serving as legal advisor and Houlihan Lokey is serving as investment banker to an ad hoc group of lenders that entered into the RSA.<\/p>\n

\nAbout LifeScan<\/b><\/p>\n

\nLifeScan is a global leader in blood glucose monitoring and digital health technology and has a vision to create a world without limits for people with diabetes. More than 20 million people and their caregivers around the world count on LifeScan’s OneTouch\u00ae brand products to manage their diabetes. Together, LifeScan and OneTouch\u00ae improve the quality of life for people with diabetes with products and digital platforms defined by simplicity, accuracy, and trust. For more information, please visit LifeScan.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia
\n
<\/b>C Street Advisory Group
\n
lifescan@thecstreet.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Initiates Prearranged Financial Restructuring Process to Significantly Strengthen Balance Sheet Operations Continue in the Ordinary Course, Including Full Continuity of OneTouch\u00ae Glucose Measurement and Management Offerings MALVERN, Pa.–(BUSINESS WIRE)–LifeScan, Inc. (\u201cLifeScan\u201d or the \u201cCompany\u201d), a world leader in blood glucose monitoring, today announced that it has entered into a Restructuring Support Agreement (\u201cRSA\u201d) with its … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61587","6":"format-standard","7":"category-industry"},"yoast_head":"\nLifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Initiates Prearranged Financial Restructuring Process to Significantly Strengthen Balance Sheet Operations Continue in the Ordinary Course, Including Full Continuity of OneTouch\u00ae Glucose Measurement and Management Offerings MALVERN, Pa.–(BUSINESS WIRE)–LifeScan, Inc. (\u201cLifeScan\u201d or the \u201cCompany\u201d), a world leader in blood glucose monitoring, today announced that it has entered into a Restructuring Support Agreement (\u201cRSA\u201d) with its ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-16T02:03:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250715827575\/en\/2524241\/22\/Lifescan_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments\",\"datePublished\":\"2025-07-16T02:03:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/\"},\"wordCount\":760,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250715827575\\\/en\\\/2524241\\\/22\\\/Lifescan_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/\",\"name\":\"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250715827575\\\/en\\\/2524241\\\/22\\\/Lifescan_Logo.jpg\",\"datePublished\":\"2025-07-16T02:03:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250715827575\\\/en\\\/2524241\\\/22\\\/Lifescan_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250715827575\\\/en\\\/2524241\\\/22\\\/Lifescan_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/","og_locale":"en_US","og_type":"article","og_title":"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments - Pharma Trend","og_description":"Initiates Prearranged Financial Restructuring Process to Significantly Strengthen Balance Sheet Operations Continue in the Ordinary Course, Including Full Continuity of OneTouch\u00ae Glucose Measurement and Management Offerings MALVERN, Pa.–(BUSINESS WIRE)–LifeScan, Inc. (\u201cLifeScan\u201d or the \u201cCompany\u201d), a world leader in blood glucose monitoring, today announced that it has entered into a Restructuring Support Agreement (\u201cRSA\u201d) with its ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/","og_site_name":"Pharma Trend","article_published_time":"2025-07-16T02:03:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250715827575\/en\/2524241\/22\/Lifescan_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments","datePublished":"2025-07-16T02:03:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/"},"wordCount":760,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250715827575\/en\/2524241\/22\/Lifescan_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/","url":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/","name":"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250715827575\/en\/2524241\/22\/Lifescan_Logo.jpg","datePublished":"2025-07-16T02:03:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250715827575\/en\/2524241\/22\/Lifescan_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250715827575\/en\/2524241\/22\/Lifescan_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lifescan-reaches-milestone-transaction-to-improve-financial-flexibility-and-enable-future-focused-investments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61587"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61587\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}